The CF AMR Syndicate is discussed in Cystic Fibrosis Trust’s Research in focus: Antimicrobial resistance in Cystic Fibrosis report.
Read more about how the partnership is attempting to get more antimicrobial drugs to people with cystic fibrosis faster by bringing together those with the condition and experts from academia and industry to identify and overcome barriers during the drug discovery and development process.
